Abstract

In C. elegans, ablation of germline stem cells (GSCs) extends lifespan, but also increases fat accumulation and alters lipid metabolism, raising the intriguing question of how these effects might be related. Here we show that a lack of GSCs results in a broad transcriptional reprogramming, in which the conserved detoxification regulator SKN-1/Nrf increases stress resistance, proteasome activity, and longevity. SKN-1 also activates diverse lipid metabolism genes and reduces fat storage, thereby alleviating the increased fat accumulation caused by GSC absence. Surprisingly, SKN-1 is activated by signals from this fat, which appears to derive from unconsumed yolk that was produced for reproduction. We conclude that SKN-1 plays a direct role in maintaining lipid homeostasis, in which it is activated by lipids. This SKN-1 function may explain the importance of mammalian Nrf proteins in fatty liver disease, and suggests that particular endogenous or dietary lipids might promote health through SKN-1/Nrf.

Article and author information

Author details

  1. Michael J Steinbaugh

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Sri Devi Narasimhan

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Stacey Robida-Stubbs

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Lorenza E Moronetti Mazzeo

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Jonathan M Dreyfuss

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. John M Hourihan

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Prashant Raghavan

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Theresa N Operaña

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Reza Esmaillie

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. T Keith Blackwell

    Research Division, Joslin Diabetes Center, Boston, United States
    For correspondence
    keith.blackwell@joslin.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Kang Shen, Howard Hughes Medical Institute, Stanford University, United States

Version history

  1. Received: March 31, 2015
  2. Accepted: July 9, 2015
  3. Accepted Manuscript published: July 21, 2015 (version 1)
  4. Version of Record published: August 19, 2015 (version 2)
  5. Version of Record updated: January 25, 2017 (version 3)

Copyright

© 2015, Steinbaugh et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,176
    views
  • 1,461
    downloads
  • 168
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michael J Steinbaugh
  2. Sri Devi Narasimhan
  3. Stacey Robida-Stubbs
  4. Lorenza E Moronetti Mazzeo
  5. Jonathan M Dreyfuss
  6. John M Hourihan
  7. Prashant Raghavan
  8. Theresa N Operaña
  9. Reza Esmaillie
  10. T Keith Blackwell
(2015)
Lipid-mediated regulation of SKN-1/Nrf in response to germ cell absence
eLife 4:e07836.
https://doi.org/10.7554/eLife.07836

Share this article

https://doi.org/10.7554/eLife.07836

Further reading

    1. Cancer Biology
    2. Cell Biology
    Alex Weiss, Cassandra D'Amata ... Madeline N Hayes
    Research Article

    High-throughput vertebrate animal model systems for the study of patient-specific biology and new therapeutic approaches for aggressive brain tumors are currently lacking, and new approaches are urgently needed. Therefore, to build a patient-relevant in vivo model of human glioblastoma, we expressed common oncogenic variants including activated human EGFRvIII and PI3KCAH1047R under the control of the radial glial-specific promoter her4.1 in syngeneic tp53 loss-of-function mutant zebrafish. Robust tumor formation was observed prior to 45 days of life, and tumors had a gene expression signature similar to human glioblastoma of the mesenchymal subtype, with a strong inflammatory component. Within early stage tumor lesions, and in an in vivo and endogenous tumor microenvironment, we visualized infiltration of phagocytic cells, as well as internalization of tumor cells by mpeg1.1:EGFP+ microglia/macrophages, suggesting negative regulatory pressure by pro-inflammatory cell types on tumor growth at early stages of glioblastoma initiation. Furthermore, CRISPR/Cas9-mediated gene targeting of master inflammatory transcription factors irf7 or irf8 led to increased tumor formation in the primary context, while suppression of phagocyte activity led to enhanced tumor cell engraftment following transplantation into otherwise immune-competent zebrafish hosts. Altogether, we developed a genetically relevant model of aggressive human glioblastoma and harnessed the unique advantages of zebrafish including live imaging, high-throughput genetic and chemical manipulations to highlight important tumor-suppressive roles for the innate immune system on glioblastoma initiation, with important future opportunities for therapeutic discovery and optimizations.

    1. Cancer Biology
    2. Cell Biology
    Ian Lorimer
    Insight

    Establishing a zebrafish model of a deadly type of brain tumor highlights the role of the immune system in the early stages of the disease.